Home Newsfeeds Janney Montgomery Scott Downgrades South Jersey Indus to Neutral

Janney Montgomery Scott Downgrades South Jersey Indus to Neutral

Janney Montgomery Scott analyst Michael Gaugler downgrades South Jersey Indus (NYSE:SJI) from Buy to Neutral.

byBenzinga Newsdesk

January 9, 2023

1 minute read

Janney Montgomery Scott analyst Michael Gaugler downgrades South Jersey Indus (NYSE:SJI) from Buy to Neutral.

Baidu To Rally Around 31%? Here Are 10 Other Analyst Forecasts For Tuesday

By Lisa Levin

June 20, 7:59 AM

Keybanc boosted the price target for Howmet Aerospace Inc. (NYSE: HWM) from $47 to $50. Keybanc analyst Philip Gibbs maintained an Overweight rating. Howmet Aerospace shares fell 0.1% to close at $45.98 on Friday.

ACVA

Macy’s In The Crosshairs: Investors Prepare For A Showdown Over $5.8B Bid

By Benzinga Neuro

January 21, 7:40 PM

An investor group, which submitted a $5.8 billion bid for Macy's Inc. (NYSE: M), is considering a direct appeal to shareholders if negotiations with the department store giant do not pr

Applied DNA Ships First saRNA IVT Template Generated By Linea DNA Platform

By Benzinga Newsdesk

November 9, 10:29 AM

Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that it has successfully manufactured and shipped its first research use only quantity of

APDN

MedAvail Receives Nasdaq Notification Of Non-Compliance Related To Delayed Quarterly Report On Form 10-Q

By Benzinga Newsdesk

November 17, 5:14 PM

MedAvail Holdings, Inc. (NASDAQ:MDVL) ("MedAvail" or the "Company"), an innovative pharmacy technology company, announced today that on November 16, 2023, the Company received a delinquency notification letter from the

MDVL

Janney Montgomery Scott Downgrades South Jersey Indus to Neutral

Related Posts

Baidu To Rally Around 31%? Here Are 10 Other Analyst Forecasts For Tuesday

Macy’s In The Crosshairs: Investors Prepare For A Showdown Over $5.8B Bid

Applied DNA Ships First saRNA IVT Template Generated By Linea DNA Platform

MedAvail Receives Nasdaq Notification Of Non-Compliance Related To Delayed Quarterly Report On Form 10-Q